MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
Oct 3 closing price
Price
$50.49
Change
+$1.59 (+3.25%)
Capitalization
2.43B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HAE with price predictions
Oct 03, 2025

HAE in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 25, 2025

HAE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where HAE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HAE's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where HAE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HAE as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HAE entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.757) is normal, around the industry mean (61.354). P/E Ratio (14.954) is within average values for comparable stocks, (37.462). Projected Growth (PEG Ratio) (0.926) is also within normal values, averaging (1.691). HAE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.873) is also within normal values, averaging (81.049).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HAE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HAE is expected to report earnings to $1.11 per share on November 05

Haemonetics Corp HAE Stock Earnings Reports
Q3'25
Est.
$1.11
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
The last earnings report on August 07 showed earnings per share of $1.10, beating the estimate of $1.01. With 752.32K shares outstanding, the current market capitalization sits at 2.43B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIVHX20.470.16
+0.79%
American Funds International Vntg R-2E
KGLAX17.840.11
+0.62%
Kinetics Global Adv A
AWPYX22.470.05
+0.22%
AB Sustainable Intl Thematic Advisor
JICCX84.090.11
+0.13%
JPMorgan US Sustainable Leaders C
MCLOX17.380.02
+0.12%
BlackRock Global Allocation Inv C

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with MXCT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+3.25%
MXCT - HAE
49%
Loosely correlated
+6.21%
ATR - HAE
41%
Loosely correlated
+0.03%
GH - HAE
39%
Loosely correlated
+2.25%
CERS - HAE
38%
Loosely correlated
+3.97%
VREX - HAE
37%
Loosely correlated
+0.67%
More

Groups containing HAE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+3.25%
Medical/Nursing Services
industry (224 stocks)
33%
Loosely correlated
+1.62%
Health Services
industry (434 stocks)
28%
Poorly correlated
+1.31%